Asahi Kasei Corporate Venture Capital
Venture capital · Menlo Park, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio4 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Sila Nanotechnologies
22Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Sila Nanotechnologies | Energy | Active | Jul 11, 2024 | $1.2B |
| Aspect Biosystems | Biotech | Active | — | — |
| Genalyte | Medtech | Active | — | — |
| Primus Pharmaceuticals | Biotech | Active | — | — |
| Nuvation Bio | Biotech | Public | Oct 20, 2020 | $275.3M |
Peer ranks
Portfolio size#81
Portfolio exits#160
Raises, 12 months#88
Co-investors#95
Co-investors
- Samsung Strategy and Innovation CenterVenture capital2 shared
- Andreessen HorowitzVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Blackstone Life SciencesVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Deerfield Capital ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- General CatalystVenture capital1 shared
- GVVenture capital1 shared
- Matrix PartnersVenture capital1 shared
Sectors
- Biotech3
- Energy1
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.